Dashboard
Manage Tickers

NTRA Natera, Inc.

Nasdaq natera.com


$ 204.96 $ 3.61 (1.8 %)    

Friday, 14-Nov-2025 15:54:50 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 204.28
$ 196.07
$ 204.96 x 75
$ 205.29 x 26
$ 195.62 - $ 205.39
$ 125.38 - $ 212.21
1,289,082
na
28.19B
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-28-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-07-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 03-15-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-15-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

druckenmiller-opens-position-in-amazon-closes-microsoft--heres-more-of-duquesnes-biggest-q3-moves
Druckenmiller Opens Position In Amazon, Cl...
11/14/2025 21:59:21

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven...

stephens--co-maintains-overweight-on-natera-raises-price-target-to-235
Stephens & Co. Maintains Overweight on Nat...
11/13/2025 14:37:44

Stephens & Co. analyst Mason Carrico maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $...

piper-sandler-maintains-overweight-on-natera-raises-price-target-to-230
Piper Sandler Maintains Overweight on Nate...
11/11/2025 17:08:32

Piper Sandler analyst David Westenberg maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $22...

morgan-stanley-maintains-overweight-on-natera-raises-price-target-to-220
Morgan Stanley Maintains Overweight on Nat...
11/11/2025 16:47:26

Morgan Stanley analyst Tejas Savant maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $195 t...

canaccord-genuity-maintains-buy-on-natera-raises-price-target-to-250
Canaccord Genuity Maintains Buy on Natera,...
11/07/2025 21:54:58

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $200 to $250.

jp-morgan-maintains-overweight-on-natera-raises-price-target-to-240
JP Morgan Maintains Overweight on Natera, ...
11/07/2025 20:04:37

JP Morgan analyst Casey Woodring maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $210 to $...

wells-fargo-maintains-equal-weight-on-natera-raises-price-target-to-190
Wells Fargo Maintains Equal-Weight on Nate...
11/07/2025 18:52:58

Wells Fargo analyst Brandon Couillard maintains Natera (NASDAQ:NTRA) with a Equal-Weight and raises the price target from $1...

barclays-maintains-overweight-on-natera-raises-price-target-to-230
Barclays Maintains Overweight on Natera, R...
11/07/2025 15:42:17

Barclays analyst Luke Sergott maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $210 to $230.

evercore-isi-group-maintains-outperform-on-natera-raises-price-target-to-250
Evercore ISI Group Maintains Outperform on...
11/07/2025 14:42:11

Evercore ISI Group analyst Daniel Markowitz maintains Natera (NASDAQ:NTRA) with a Outperform and raises the price target fro...

btig-maintains-buy-on-natera-raises-price-target-to-230
BTIG Maintains Buy on Natera, Raises Price...
11/07/2025 09:57:33

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $210 to $230.

natera-raises-fy2025-sales-guidance-from-2020b-2100b-to-2180b-2260b-vs-2091b-est
Natera Raises FY2025 Sales Guidance from $...
11/06/2025 21:08:13

Natera (NASDAQ:NTRA) raises FY2025 sales outlook from $2.020 billion-$2.100 billion to $2.180 billion-$2.260 billion vs $2.091 ...

natera-q3-eps-064-misses-040-estimate-sales-592183m-beat-512753m-estimate
Natera Q3 EPS $(0.64) Misses $(0.40) Estim...
11/06/2025 21:07:32

Natera (NASDAQ:NTRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.40) by 6...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

natera-to-expand-fetal-focus-test-to-cover-20-genes-marking-advancement-in-single-gene-noninvasive-prenatal-testing-new-expanded-panel-to-launch-in-q4-2025
Natera To Expand Fetal Focus Test To Cover...
10/31/2025 11:04:47

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand its...

proceed-crc-trial-shows-nateras-blood-test-achieves-225-sensitivity-and-915-specificity-for-advanced-adenoma-detection
PROCEED-CRC Trial Shows Natera's Blood Tes...
10/28/2025 11:08:26

a-glimpse-into-the-expert-outlook-on-natera-through-8-analysts
A Glimpse Into The Expert Outlook On Nater...
10/23/2025 18:00:59

btig-maintains-buy-on-natera-raises-price-target-to-210
BTIG Maintains Buy on Natera, Raises Price...
10/23/2025 17:29:30

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $200 to $210.

nateras-signatera-demonstrates-predictive-power-in-imvigor011-guiding-tecentriq-use-for-improved-bladder-cancer-outcomes
Natera's Signatera Demonstrates Predictive...
10/20/2025 06:42:14

Data to be featured in Presidential Symposium at ESMOSignatera™ changes the paradigm by expanding the adjuvant decision window,...

canaccord-genuity-maintains-buy-on-natera-maintains-200-price-target
Canaccord Genuity Maintains Buy on Natera,...
10/14/2025 14:08:29

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and maintains $200 price target.

heres-how-much-1000-invested-in-natera-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Natera 5...
10/13/2025 20:00:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION